The Role of 18F-FDG-PET for Staging and Prognostication

Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma

NCT00915096 ·Status: COMPLETED

Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT

NCT04464590 ·Status: COMPLETED

Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma

NCT03891914 ·Status: COMPLETED ·Phase: PHASE3

Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma

NCT04747561 ·Status: UNKNOWN ·Phase: NA

18F-FDG Tomography and Labeled Leukocyte Scintigraphy

NCT05994768 ·Status: COMPLETED

An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation

NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

NCT01248000 ·Status: COMPLETED

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

NCT02317393 ·Status: COMPLETED ·Phase: PHASE2

Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma

NCT06737835 ·Status: NOT_YET_RECRUITING

18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma

NCT04317313 ·Status: COMPLETED

18F FES-PET/MRI for Tailoring Treatment of Luminal a and Lobular Breast Cancer

NCT05982496 ·Status: NOT_YET_RECRUITING ·Phase: NA

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

NCT00004138 ·Status: COMPLETED ·Phase: NA

Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate Cancer

NCT06167629 ·Status: RECRUITING

A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma

NCT05448404 ·Status: UNKNOWN ·Phase: NA

18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy

NCT03741231 ·Status: COMPLETED

Diagnostic Imaging of Myeloma Bone Lesions

NCT03147326 ·Status: COMPLETED ·Phase: NA

Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer

NCT02664792 ·Status: COMPLETED ·Phase: NA

Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.

NCT00200668 ·Status: TERMINATED ·Phase: NA

Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

NCT03262389 ·Status: COMPLETED ·Phase: PHASE2

The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma

NCT05645484 ·Status: UNKNOWN

Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

NCT00433433 ·Status: UNKNOWN ·Phase: PHASE3

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma

NCT03051581 ·Status: UNKNOWN ·Phase: NA

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

NCT00110006 ·Status: WITHDRAWN ·Phase: NA

18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma

NCT00775268 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

NCT06795113 ·Status: RECRUITING